Company intelligence

NorthStar Medical Technologies

Biotech

Is this your company? Get featured or correct your listing →

Suggest a correction

Recent changes

  1. Oct 6, 2026Raised Up to $185M Pulse 2.0

Funding History

1 event · sources dated per row
DateEventAmountValuationInvestorsSource
Oct 6, 2026debtUp to $185M—
Hercules Capital
Pulse 2.0

Latest Pulse

  1. NorthStar Lands $185M to Scale Cancer Isotope SupplyNorthStar Medical Technologies secured a growth-capital facility of up to $185 million from Hercules Capital to expand production of the cancer isotope actinium-225.→

Coverage Timeline

newest first
  1. Oct 6, 2026FUNDINGNorthStar Lands $185M to Scale Cancer Isotope Supply$185M growth facility→

All Coverage

FUNDING

NorthStar Lands $185M to Scale Cancer Isotope Supply

Illustration for: NorthStar Lands $185M to Scale Cancer Isotope Supply
FUNDING$185M growth facility

NorthStar Lands $185M to Scale Cancer Isotope Supply

NorthStar Medical Technologies secured a growth-capital facility of up to $185 million from Hercules Capital to expand production of the cancer isotope actinium-225.

DEEP DIVE

Related Companies

Same sector
Scribe TherapeuticsAttovia TherapeuticsIambic TherapeuticsApnimedRetension PharmaceuticalsEli Lilly
Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction